Rodman & Renshaw initiated coverage of Zenas BioPharma (ZBIO) with a Buy rating and $34 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ZBIO: Opening Day: Another trio of biotech IPOs make Friday debut Zenas BioPharma initiated with a Buy at Jefferies Zenas BioPharma initiated with a Buy at Citi Zenas BioPharma initiated with a Buy at Guggenheim Zenas BioPharma initiated with an Overweight at Morgan Stanley